Tech Company Financing Transactions
Anpac Bio-Medical Science Funding Round
Anpac Bio-Medical Science closed a $2 million funding round on 12/31/2015. Investors included Shanghai Ruizhang Investment.
Transaction Overview
Company Name
Announced On
12/31/2015
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Anpac will use our latest investments to further CDA research and operations in the United States.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
500 Capitol Mall 2350
Sacramento, CA 95814
USA
Sacramento, CA 95814
USA
Phone
Website
Email Address
Overview
Anpac Bio-Medical Science Co., Ltd. (Anpac) was founded in 2008 by world-renowned scientist, inventor, engineer and entrepreneur Chief Executive Officer Dr. Chris Yu, and a multi-national team of medical, biomedical and nanotechnology scientists, and engineering experts.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chris Yu
Chief Scientific Officer
Herbert Yu
President
Shaun Gong
VP - Operations
Sharon Vorse-Yu
Browse more venture capital transactions:
Prev: 12/31/2015: New Wallet venture capital transaction
Next: 12/31/2015: PLUMgrid venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs